查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1787948

呼吸照護設備市場預測至 2032 年：按設備類型、患者類型、疾病類型、技術、最終用戶和地區進行的全球分析

Respiratory Care Devices Market Forecasts to 2032 - Global Analysis By Device Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices and Consumables & Accessories), Patient Type, Disease Type, Technology, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球呼吸照護設備市場預計在 2025 年達到 240 億美元，到 2032 年將達到 420 億美元，預測期內的複合年成長率為 8.3%。

呼吸照護設備是指旨在透過支持或增強呼吸功能來輔助呼吸的醫療設備。它們用於治療氣喘、慢性阻塞性肺病(COPD) 和睡眠呼吸中止症等呼吸系統疾病。此類設備包括氧氣濃縮機、人工呼吸器、霧化器、持續性呼吸道正壓通氣 (CPAP) 機和肺計量計。這些設備能夠促進氣流、輸送藥物並監測肺部功能，在維持充足的氧氣水平和整體肺部健康方面發揮關鍵作用。

根據美國肺臟協會2023年2月發表的報導，超過3,400萬美國人患有慢性阻塞性肺病、氣喘、慢性支氣管炎和肺氣腫等慢性肺部疾病。

慢性呼吸系統疾病盛行率上升

氣喘、慢性阻塞性肺病 (COPD) 和睡眠呼吸中止症等慢性呼吸系統疾病在全球日益加重，是推動其發展的主要動力。人口老化、吸菸習慣、空氣污染和職業危害等因素也加劇了盛行率的上升。全球醫療保健系統面臨著提供早期診斷和有效治療的壓力，這刺激了對呼吸照護設備的需求。意識提升和政府篩檢措施的推進進一步推動了市場應用。這種日益成長的健康意識為呼吸技術的創新提供了持續的動力。

先進呼吸設備高成本

儘管需求不斷成長，但現代呼吸照護設備（包括非侵入性人工呼吸器、持續性呼吸道正壓通氣機和氧氣濃縮器）的高昂成本仍然是其廣泛應用的障礙，尤其是在中低收入國家。許多醫療機構面臨預算限制，這限制了它們升級到先進技術的能力。此外，新興經濟體的患者面臨經濟困難，限制了其家庭使用。報銷和自付費用的差異進一步阻礙了這些設備的普及，減緩了它們在公共和私營醫療部門的普及速度。

可攜式和智慧型設備的技術進步

攜帶式和連網呼吸護理設備的快速發展帶來了巨大的市場機會。智慧吸入器、無線霧化器和整合應用程式的氧氣療法系統能夠即時監測並提高依從性。這些技術創新尤其有利於家庭醫療保健和遠距患者管理。人工智慧和物聯網與呼吸設備的整合正在改變疾病管理，實現預測性診斷和主動護理。這項技術轉變預計將為製造商開闢新的收益來源。

嚴格的監管核准流程

市場面臨嚴格的監管標準和漫長的核准週期所帶來的威脅。獲得FDA或CE認證需要複雜的臨床試驗、文件記錄和合規性審核。上市延遲會增加研發成本，並阻礙中小企業的創新。此外，頻繁變化的合規框架可能會擾亂打入市場策略。製造商必須應對不同地區在安全性、有效性和品管要求方面的差異，這可能會延遲產品上市，並限制呼吸護理解決方案的國際擴充性。

COVID-19的影響：

新冠疫情對呼吸照護設備市場產生了雙重影響。 2020年至2021年，疫情推動了人工呼吸器、氧氣療法設備和監測系統前所未有的需求，同時也暴露了供應鏈的脆弱性，並導致產品短缺。疫情爆發後，醫療機構將呼吸系統疾病防範工作放在首位，並加強了對重症加護基礎設施的長期投資。疫情也加速了居家呼吸照護、遠端監測工具和可攜式設備的普及，從根本上重塑了已開發地區和發展中地區的醫療服務模式。

治療設備領域預計將成為預測期內最大的領域

預計治療設備領域將在預測期內佔據最大的市場佔有率，這得益於其在治療慢性阻塞性肺病 (COPD)、氣喘和睡眠呼吸中止症等慢性呼吸系統疾病方面的應用日益廣泛。醫院和家庭對人工呼吸器、持續性正壓呼吸器 (CPAP) 和霧化器的需求不斷成長，推動了該領域的發展。非侵入式和可攜式治療解決方案的技術創新進一步推動了這些設備的普及。醫療保健投資的不斷成長以及患者對居家照護的偏好，正在鞏固該領域在全球市場的主導地位。

慢性阻塞性肺病(COPD) 領域預計將在預測期內實現最高的複合年成長率

預計慢性阻塞性肺病(COPD) 細分市場將在預測期內實現最高成長率，這得益於盛行率的上升和管理意識的增強。空氣污染加劇、菸草使用增加以及人口老化等因素正在推高診斷率。早期療育的需求以及吸入器和氧氣濃縮機等 COPD 專用設備的日益普及，正在推動市場擴張。 COPD 監測領域的持續技術創新和數位化整合預計將維持這一快速成長動能。

比最大的地區

受快速都市化、空氣污染加劇和人口老化的影響，預計亞太地區將在預測期內佔據最大的市場佔有率。由於環境和生活方式因素，中國、印度和日本等國家的呼吸系統疾病發生率正在上升。政府的醫療改革和農村地區醫療服務可近性的提高也促進了醫療設備的普及。此外，醫療旅遊業和不斷成長的國內製造能力正使亞太地區成為一個戰略市場樞紐。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這得益於技術創新、強大的醫療基礎設施和高度的患者意識。該地區受益於先進呼吸治療方法的早期採用、強大的保險覆蓋範圍以及支持技術創新的法規結構。由於人口老化和生活方式的改變，美國和加拿大的慢性呼吸系統疾病盛行率也在上升。家庭醫療保健和智慧監測工具的日益普及也推動了該地區的成長。

提供免費客製化：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球呼吸護理設備市場（按設備類型）

  • 治療設備
    • 正氣壓（PAP）裝置
    • 吸入器
    • 人工呼吸器
    • 加濕器
    • 噴霧器
  • 監控設備
    • 脈動式血氧監測儀系統
  • 診斷設備
  • 耗材及配件

6. 全球呼吸照護設備市場（依患者類型）

  • 孩子們
  • 成人
  • 老年人

7. 全球呼吸照護設備市場（依疾病類型）

  • 慢性阻塞性肺病（COPD）
  • 氣喘
  • 睡眠呼吸中止症
  • 感染疾病
  • 其他疾病類型

8. 全球呼吸護理設備市場（按技術）

  • 人工呼吸器
  • 數位化智慧呼吸監測解決方案
  • 自動/基於人工智慧的人工呼吸器

9. 全球呼吸護理設備市場（按最終用戶）

  • 醫院和診所
  • 居家照護環境
  • 門診手術中心（ASC）
  • 診斷實驗室
  • 復健中心

第10章。全球呼吸照護設備市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Koninklijke Philips NV
  • Medtronic
  • ResMed
  • Masimo
  • Fisher & Paykel Healthcare Limited
  • Dragerwerk AG & Co. KGaA
  • Getinge
  • Nihon Kohden Corporation
  • GE Healthcare
  • Vyaire Medical, Inc.
  • Baxter International, Inc.
  • AdaptHealth, LLC
  • Teleflex Incorporated
  • Air Liquide
  • Invacare Corporation
  • ICU Medical
  • Hamilton Medical AG
  • Apex Medical Corp
  • Medline Industries, LP
  • HUM Society for Homecare
Product Code: SMRC30213

According to Stratistics MRC, the Global Respiratory Care Devices Market is accounted for $24.0 billion in 2025 and is expected to reach $42.0 billion by 2032 growing at a CAGR of 8.3% during the forecast period. Respiratory care devices are medical instruments designed to assist with breathing by supporting or enhancing respiratory function. They are used to treat individuals with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Devices in this category include oxygen concentrators, ventilators, nebulizers, CPAP machines, and spirometers. These tools facilitate airflow, deliver medication, or monitor lung performance, playing a crucial role in maintaining proper oxygen levels and overall pulmonary health.

According to the American Lung Association, which published an article in February 2023, there are more than 34 million Americans suffering from chronic lung diseases, including COPD, asthma, chronic bronchitis, and emphysema.

Market Dynamics:

Driver:

Rising prevalence of chronic respiratory diseases

The increasing global burden of chronic respiratory conditions, such as asthma, COPD, and sleep apnea, is a primary growth driver. Factors including aging populations, smoking habits, air pollution, and occupational hazards are contributing to rising incidence rates. Healthcare systems worldwide are under pressure to provide early diagnosis and efficient treatment, spurring demand for respiratory care devices. Enhanced public awareness and government screening initiatives are further catalyzing market adoption. This rising health concern is creating sustainable momentum for respiratory technology innovation.

Restraint:

High cost of advanced respiratory devices

Despite growing demand, the high cost of modern respiratory care devices-such as non-invasive ventilators, CPAP machines, and oxygen concentrators-poses a barrier to widespread adoption, especially in low- and middle-income countries. Many healthcare institutions struggle with budget constraints, limiting their ability to upgrade to advanced technologies. Moreover, patients in developing economies face affordability issues, restricting home-based usage. Insurance reimbursement gaps and out-of-pocket expenditures further aggravate this restraint, slowing down penetration in both public and private healthcare sectors.

Opportunity:

Technological advancements in portable and smart devices

The market is experiencing a significant opportunity due to the rapid development of portable and connected respiratory care devices. Smart inhalers, wireless nebulizers, and app-integrated oxygen therapy systems offer real-time monitoring and improved adherence. These innovations are especially beneficial in home healthcare and remote patient management. The integration of AI and IoT into respiratory devices is transforming disease management, allowing predictive diagnostics and proactive care. This technological shift is expected to unlock new revenue streams for manufacturers.

Threat:

Stringent regulatory approval processes

The market faces threats from rigorous regulatory standards and prolonged approval timelines. Obtaining FDA or CE certifications involves complex clinical trials, documentation, and compliance audits. Delays in market entry can increase R&D expenses and discourage smaller players from innovating. Furthermore, frequent changes in compliance frameworks can disrupt go-to-market strategies. Manufacturers must navigate regional differences in safety, efficacy, and quality control requirements, which can delay product launches and restrict international scalability of respiratory care solutions.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the respiratory care devices market. While it created an unprecedented demand spike for ventilators, oxygen therapy devices, and monitoring systems during 2020-2021, it also exposed supply chain vulnerabilities and triggered product shortages. Post-pandemic, healthcare facilities have prioritized respiratory readiness, boosting long-term investments in critical care infrastructure. The pandemic also accelerated the adoption of home-based respiratory care, telemonitoring tools, and portable devices, fundamentally reshaping care delivery models across both developed and developing regions.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to account for the largest market share during the forecast period propelled by, growing usage in treating chronic respiratory ailments like COPD, asthma, and sleep apnea. Increased demand for ventilators, CPAP devices, and nebulizers across both hospitals and home settings is boosting this segment. Technological innovation in non-invasive and portable therapeutic solutions is further enhancing adoption. Rising healthcare investments and patient preference for home care are reinforcing segment dominance across global markets.

The chronic obstructive pulmonary disease (COPD) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the chronic obstructive pulmonary disease (COPD) segment is predicted to witness the highest growth rate, influenced by the increasing prevalence of the disease and heightened awareness of its management. Factors such as rising air pollution, tobacco use, and aging populations are driving diagnosis rates. The need for early intervention, combined with expanding availability of COPD-specific devices like inhalers and oxygen concentrators, is fueling market expansion. Continuous innovation and digital integration in COPD monitoring are expected to sustain this rapid growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fuelled by, fueled by rapid urbanization, increasing air pollution, and a rising geriatric population. Countries such as China, India, and Japan are experiencing growing rates of respiratory diseases due to environmental and lifestyle factors. Government health reforms and expanding healthcare access in rural regions are also contributing to device uptake. Moreover, growing medical tourism and domestic manufacturing capacities make Asia Pacific a strategic market hub.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, technological innovation, robust healthcare infrastructure, and high patient awareness. The region benefits from early adoption of advanced respiratory therapies, strong insurance coverage, and active regulatory frameworks that support innovation. The U.S. and Canada are also experiencing rising prevalence of chronic respiratory conditions due to aging populations and lifestyle factors. The increasing shift toward home healthcare and smart monitoring tools further accelerates regional growth.

Key players in the market

Some of the key players in Respiratory Care Devices Market include Koninklijke Philips N.V., Medtronic, ResMed, Masimo, Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, Getinge, Nihon Kohden Corporation, GE Healthcare, Vyaire Medical, Inc., Baxter International, Inc., AdaptHealth, LLC, Teleflex Incorporated, Air Liquide, Invacare Corporation, ICU Medical, Hamilton Medical AG, Apex Medical Corp, Medline Industries, LP, and HUM Society for Homecare.

Key Developments:

In July 2025, ResMed introduced its first AI-powered sleep therapy platform that continuously adapts airflow based on patient breathing patterns, marking a step forward in personalized respiratory care for sleep apnea.

In June 2025, Dragerwerk AG & Co. KGaA enhanced its ventilator line by integrating advanced aerosol therapy modules, targeting improved respiratory outcomes in pediatric and neonatal intensive care units.

In April 2025, Philips expanded its homecare respiratory portfolio with a compact portable oxygen concentrator built for high-altitude environments, addressing oxygen therapy needs in under-served mountainous regions.

Device Types Covered:

  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables & Accessories

Patient Types Covered:

  • Pediatric
  • Adult
  • Geriatric

Disease Types Covered:

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Other Disease Types

Technologies Covered:

  • Mechanical Respiratory Devices
  • Digital & Smart Respiratory Monitoring Solutions
  • Automated/AI-based Ventilatory Devices

End Users Covered:

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers (ASCs)
  • Diagnostic Laboratories
  • Rehabilitation Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Respiratory Care Devices Market, By Device Type

  • 5.1 Introduction
  • 5.2 Therapeutic Devices
    • 5.2.1 Positive Airway Pressure (PAP) Devices
    • 5.2.2 Inhalers
    • 5.2.3 Ventilators
    • 5.2.4 Humidifiers
    • 5.2.5 Nebulizers
  • 5.3 Monitoring Devices
    • 5.3.1 Pulse Oximeters
  • 5.4 Diagnostic Devices
  • 5.5 Consumables & Accessories

6 Global Respiratory Care Devices Market, By Patient Type

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult
  • 6.4 Geriatric

7 Global Respiratory Care Devices Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
  • 7.3 Asthma
  • 7.4 Sleep Apnea
  • 7.5 Infectious Disease
  • 7.6 Other Disease Types

8 Global Respiratory Care Devices Market, By Technology

  • 8.1 Introduction
  • 8.2 Mechanical Respiratory Devices
  • 8.3 Digital & Smart Respiratory Monitoring Solutions
  • 8.4 Automated/AI-based Ventilatory Devices

9 Global Respiratory Care Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Home Care Settings
  • 9.4 Ambulatory Surgical Centers (ASCs)
  • 9.5 Diagnostic Laboratories
  • 9.6 Rehabilitation Centers

10 Global Respiratory Care Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Koninklijke Philips N.V.
  • 12.2 Medtronic
  • 12.3 ResMed
  • 12.4 Masimo
  • 12.5 Fisher & Paykel Healthcare Limited
  • 12.6 Dragerwerk AG & Co. KGaA
  • 12.7 Getinge
  • 12.8 Nihon Kohden Corporation
  • 12.9 GE Healthcare
  • 12.10 Vyaire Medical, Inc.
  • 12.11 Baxter International, Inc.
  • 12.12 AdaptHealth, LLC
  • 12.13 Teleflex Incorporated
  • 12.14 Air Liquide
  • 12.15 Invacare Corporation
  • 12.16 ICU Medical
  • 12.17 Hamilton Medical AG
  • 12.18 Apex Medical Corp
  • 12.19 Medline Industries, LP
  • 12.20 HUM Society for Homecare

List of Tables

  • Table 1 Global Respiratory Care Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Respiratory Care Devices Market Outlook, By Device Type (2024-2032) ($MN)
  • Table 3 Global Respiratory Care Devices Market Outlook, By Therapeutic Devices (2024-2032) ($MN)
  • Table 4 Global Respiratory Care Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2024-2032) ($MN)
  • Table 5 Global Respiratory Care Devices Market Outlook, By Inhalers (2024-2032) ($MN)
  • Table 6 Global Respiratory Care Devices Market Outlook, By Ventilators (2024-2032) ($MN)
  • Table 7 Global Respiratory Care Devices Market Outlook, By Humidifiers (2024-2032) ($MN)
  • Table 8 Global Respiratory Care Devices Market Outlook, By Nebulizers (2024-2032) ($MN)
  • Table 9 Global Respiratory Care Devices Market Outlook, By Monitoring Devices (2024-2032) ($MN)
  • Table 10 Global Respiratory Care Devices Market Outlook, By Pulse Oximeters (2024-2032) ($MN)
  • Table 11 Global Respiratory Care Devices Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 12 Global Respiratory Care Devices Market Outlook, By Consumables & Accessories (2024-2032) ($MN)
  • Table 13 Global Respiratory Care Devices Market Outlook, By Patient Type (2024-2032) ($MN)
  • Table 14 Global Respiratory Care Devices Market Outlook, By Pediatric (2024-2032) ($MN)
  • Table 15 Global Respiratory Care Devices Market Outlook, By Adult (2024-2032) ($MN)
  • Table 16 Global Respiratory Care Devices Market Outlook, By Geriatric (2024-2032) ($MN)
  • Table 17 Global Respiratory Care Devices Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 18 Global Respiratory Care Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2024-2032) ($MN)
  • Table 19 Global Respiratory Care Devices Market Outlook, By Asthma (2024-2032) ($MN)
  • Table 20 Global Respiratory Care Devices Market Outlook, By Sleep Apnea (2024-2032) ($MN)
  • Table 21 Global Respiratory Care Devices Market Outlook, By Infectious Disease (2024-2032) ($MN)
  • Table 22 Global Respiratory Care Devices Market Outlook, By Other Disease Types (2024-2032) ($MN)
  • Table 23 Global Respiratory Care Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 24 Global Respiratory Care Devices Market Outlook, By Mechanical Respiratory Devices (2024-2032) ($MN)
  • Table 25 Global Respiratory Care Devices Market Outlook, By Digital & Smart Respiratory Monitoring Solutions (2024-2032) ($MN)
  • Table 26 Global Respiratory Care Devices Market Outlook, By Automated/AI-based Ventilatory Devices (2024-2032) ($MN)
  • Table 27 Global Respiratory Care Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 28 Global Respiratory Care Devices Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 29 Global Respiratory Care Devices Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 30 Global Respiratory Care Devices Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 31 Global Respiratory Care Devices Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 32 Global Respiratory Care Devices Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.